Global Blood Testing Market
World Blood Testing Market Trends Analysis Report 2022 & 2023-2030: Focus on Glucose, Lipid, COVID-19, A1C, CRP, Vitamin D, ALT, AST, Thyroid Stimulating Hormone, PSA, & Cortisol Testing
November 14, 2023 02:48 ET | Research and Markets
Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The "Blood Testing Market Size, Share & Trends Analysis Report By Test Type (Glucose, Lipid, COVID-19, A1C, CRP, Vitamin D, ALT, AST, Thyroid...
Global Market for Blood Culture Tests
Global Blood Culture Tests Strategic Business Report 2023: High Incidence Rates of Infectious Disease to Bode Well for Market
May 08, 2023 09:48 ET | Research and Markets
Dublin, May 08, 2023 (GLOBE NEWSWIRE) -- The "Blood Culture Tests - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Blood Culture...
MicrosoftTeams-image (5).png
Blood Testing Market to Reach USD 218.2 Bn by 2032 Growing at a 9.6% CAGR | TMR Study
April 14, 2023 12:30 ET | Transparency Market Research
Wilmington, Delaware, United States, April 14, 2023 (GLOBE NEWSWIRE) -- The blood testing market was valued at USD 80.2 Bn in 2021 and the global market is anticipated to reach USD 218.2 Bn....
LifeLabs Opens its Newest Ottawa Location
LifeLabs Opens its Newest Ottawa Location
October 11, 2022 12:06 ET | LifeLabs
Ottawa, Ontario, Oct. 11, 2022 (GLOBE NEWSWIRE) -- LifeLabs recently hosted the grand opening of its newest Patient Service Centre in Kanata. Dr. Merrilee Fullerton, MPP for Kanata—Carleton, joined...
Future Market Insights.png
Blood Testing Equipment Market is expected to reach a valuation of US$ 150 Bn by 2032 | Future Market Insights, Inc. NEWARK, Del, July 12, 2022 (GLOBE NEWSWIRE) -- The global blood testing equipment market is projected to reach a value of US$ 80 Bn by the end of 2022. Driven by the increasing demand for safe blood...
22157.jpg
Worldwide Blood Testing Industry to 2029 - Key Drivers & Restraints and Detailed COVID-19 Impact on Blood Testing Market
May 24, 2022 06:18 ET | Research and Markets
Dublin, May 24, 2022 (GLOBE NEWSWIRE) -- The "Global Blood Testing Market, Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. The Blood Testing Market is expected to...
ScipherTM.png
Scipher Medicine Announces PrismRA® Met Primary and Secondary Endpoints in Prospective Observational Study Predicting Inadequate Response to World’s Largest-Selling Drug Class
June 24, 2021 08:00 ET | Scipher Medicine Corporation
Blood Test Predicts TNFi Response in Patients Both Naïve to and Experienced with TherapyProviders Can Access Patient-Specific Data for Optimized Therapy Selection WALTHAM, Mass., June 24, 2021 ...
ScipherTM.png
WellDyne Partners with Scipher Medicine to Improve Patient Outcomes and Lower Costs for Rheumatoid Arthritis Care
February 11, 2021 08:00 ET | Scipher Medicine Corporation
WALTHAM, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with their most effective therapy, today announced a partnership with WellDyne, a...
ScipherTM.png
Scipher Medicine Brings Precision Medicine Platform to Patient-Centered MIT Initiative
February 03, 2021 08:00 ET | Scipher Medicine Corporation
WALTHAM, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with the most effective therapy, announced today they have partnered with...
Pappas_LinkedIn_Image
New Study Demonstrates Clinical Utility of PrismRA® Test in Guiding Therapy Selection for Rheumatoid Arthritis Patients
December 07, 2020 08:06 ET | Scipher Medicine Corporation
WALTHAM, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with the most effective therapy, today announced findings from a clinical utility...